The pharmaceutical industry faces rising costs, stagnant innovation, and increasing demand for personalized medicine, complicating patient access to essential treatments. Artificial Intelligence (AI), particularly machine learning, transforms the industry by accelerating drug discovery, development, and clinical trials. It enhances target identification, lead generation, optimization, and drug repurposing, while improving patient selection, virtual trials, real-time monitoring, risk assessment, and manufacturing through predictive maintenance and process optimization. To fully harness AI's potential, the industry must address Regulatory, ethical, and data privacy challenges. How can these obstacles be overcome?
Here is a comprehensive perspective we give you. Pharma Focus Asia published our insights on how AI, especially machine learning, addresses these pressing issues in the pharmaceutical industry. Read it here.
Click here to read the complete "Pharma Focus Asia" Issue.